Skip to main content
Clinical Trials/NCT05429489
NCT05429489
Completed
Not Applicable

Comparison of the Efficacy of Bilevel Erector Spinae Plane Block and Single Level Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries

National Cancer Institute, Egypt1 site in 1 country126 target enrollmentJune 27, 2022

Overview

Phase
Not Applicable
Intervention
Bilevel erector spinae plane block
Conditions
Analgesia
Sponsor
National Cancer Institute, Egypt
Enrollment
126
Locations
1
Primary Endpoint
Total analgesic requisite
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study aims at comparing the analgesic efficacy and safety of bilevel erector spinae versus single level versus general anesthesia for breast cancer surgeries

Registry
clinicaltrials.gov
Start Date
June 27, 2022
End Date
January 10, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
National Cancer Institute, Egypt
Responsible Party
Principal Investigator
Principal Investigator

Walaa Youssef Elsabeeny

Assistant professor of Anesthesia and Pain management

National Cancer Institute, Egypt

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with breast cancer

Exclusion Criteria

  • Patient refusal
  • coagulation defects
  • bone metastases
  • abnormal kidney and/or liver function tests

Arms & Interventions

Bilevel erector spinae plane block

Bilevel erector spinae block at 3rd and 5th thoracic vertebral levels

Intervention: Bilevel erector spinae plane block

Single level erector spinae plane block

single level erector spinae plane block at 5th thoracic vertebral levels

Intervention: Single level erector spinae plane block

Intravenous morphine

Intravenous morphine 0.1 mg/ kg

Intervention: Intravenous morphine

Outcomes

Primary Outcomes

Total analgesic requisite

Time Frame: First 24 hours postoperatively

total postoperative morphine consumption

Study Sites (1)

Loading locations...

Similar Trials